Results 31 to 40 of about 18,114 (168)

Cytopathology Practice in the COVID-19 Era: Focus on Sample Workload

open access: yesJournal of Molecular Pathology, 2021
Since the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak was declared a pandemic, the magnitude of coronavirus disease 2019 (COVID-19) has continued to grow, putting an unprecedented strain on all medical fields.
Antonino Iaccarino   +7 more
doaj   +1 more source

Dr. Leena Krogerus: A Grand Old Lady of the Finnish Cytopathology and My Cytopathology Mum

open access: yesDiagnostic Cytopathology, EarlyView.
ABSTRACT The communication introduces former President of the Finnish Society of Clinical Cytology and organizer of the European Congress of Cytology in Rovaniemi, Dr. Leena Krogerus. She played an important role in the formation of my cytopathology career as she led my path in cytopathology education, research, and leadership.
Ivana Kholová
wiley   +1 more source

A comparative study of diagnostic accuracy in 3026 pleural biopsies and matched pleural effusion cytology with clinical correlation

open access: yesCancer Medicine, 2023
Background Pleural effusion can be caused by a wide range of benign and malignant conditions. Pleural biopsy and effusion cytology represent two key methods of pathological diagnosis.
Ivan K. Poon   +9 more
doaj   +1 more source

Cytological Samples: An Asset for the Diagnosis and Therapeutic Management of Patients with Lung Cancer

open access: yesCells, 2023
Background: Lung cancer has become the leading cause of cancer death for men and women. Most patients are diagnosed at an advanced stage when surgery is no longer a therapeutic option. At this stage, cytological samples are often the less invasive source
Diane Frankel   +8 more
doaj   +1 more source

Two Pillars of My Path in Cytopathology: Mentorship From Training to Practice

open access: yesDiagnostic Cytopathology, EarlyView.
ABSTRACT Mentorship has been a cornerstone of my professional development in cytopathology, shaping both my diagnostic acumen and academic identity. Under the guidance of Dr. Claire Michael during residency and fellowship, I was introduced to a culture of intellectual rigor, systems thinking, and continuous improvement.
Hamza N. Gokozan
wiley   +1 more source

Assessment of Ki-67 Proliferative Index in Cytological Samples of Nodal B-Cell Lymphomas

open access: yesDiagnostics
Background: The Ki-67 proliferative index (PI) is part of the diagnosis of nodal B-cell lymphoma (nBCL), but its determination in cytological samples is not standardized. We aimed to establish an approach for the accurate determination of the Ki-67 PI in
Mojca Založnik   +9 more
doaj   +1 more source

Endoscopic ultrasound-guided fine-needle aspiration with on-site cytopathology versus core biopsy: a comparison of both techniques performed at the same endoscopic session

open access: yesEndoscopy International Open, 2014
Background: Endoscopic ultrasound (EUS)-guided fine needle aspiration (FNA) with bedside cytopathology is the gold standard for assessment of pancreatic, subepithelial, and other lesions in close proximity to the
Michael Lin   +6 more
doaj   +1 more source

Dr. Sara E. Monaco: A Mentor Extraordinaire Who Changed Cytopathology in Rural Pennsylvania by “Making It the Best”

open access: yesDiagnostic Cytopathology, EarlyView.
ABSTRACT This report introduces Dr. Sara E. Monaco, the incoming President‐Elect of the American Society of Cytopathology (ASC) and System Director of Cytopathology at Geisinger Medical Center. Dr. Monaco has provided significant mentorship to me over the years and facilitated the development of my passion for cytopathology and education.
Terrance J. Lynn
wiley   +1 more source

ERCC1 expression correlated with EGFR and clinicopathological variables in patients with non‐small cell lung cancer. An immunocytochemical study on fine‐needle aspiration biopsies samples

open access: yesRevista Portuguesa de Pneumologia, 2014
Purpose: Expression of ERCC1 has not been well described in fine‐needle aspiration biopsies (FNABs) in patients with non‐small cell lung cancer (NSCLC).
A. Kalogeraki   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy